Reference | Age/Sex | Race | HBV | HCV | EBV | Liver cirrhosis | AFP, > 20 ng/mL | Tumor location | BCLC (0/A) | Tumor no. | Tumor size(mm) | Vascular invasion | Treatment | Recurrence | FU, months | Outcomes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
An et al [9] | 50/M | Asian | + | – | – | + | + | R | – | 1 | 35 | – | LR | Y | 6 | Alive |
Wang et al [13] | 37/F | NA | + | + | – | + | + | R | + | 1 | 32 | NA | LR | N | 52 | Alive |
Chen et al [14] | 56/M | Asian | – | + | – | + | + | R | + | 1 | 32 | – | LR | Y | 21 | Died |
Cacciato Insilla et al [15] | 81/F | NA | – | + | – | – | + | L | + | 1 | 72 | NA | LR | N | 15 | Alive |
Shinoda et al [16] | 79/M | Asian | – | – | – | – | + | L | + | 1 | 42 | – | LR | Y | 20 | Alive |
Wei et al [17] | 42/F | Asian | – | – | – |  | + | L | + | 1 | 46 | NA | LR | N | 8 | Alive |
Park et al [18] | 57/M | Asian | + | – | – | + | – | R | + | 1 | 27 | NA | LR | N | 60 | Alive |
Emil et al [19] | 50/M | White | + | + | – | + | – | NA | + | 1 | 40 | – | OLT | N | 120 | Alive |
 | 54/M | White | – | – | – | – | – | NA | + | 2 | 20 | – | OLT | Y | 92 | Died |
 | 59/M | White | + | + | – | + | – | NA | – | 4 | 50 | – | OLT | N | 96 | Alive |
 | 45/M | White | – | + | – | + | – | NA | + | 1 | 20 | – | OLT | N | 56 | Alive |
 | 64/M | White | – | – | – | + | – | NA | – | 2 | 40 | + | OLT | N | 36 | Alive |
Si et al [20] | 39/F | Latino | – | + | + | + | NA | NA | + | 1 | 10 | + | OLT | Y | 5 | Died |
Nemolato et al [21] | 47/F | NA | – | – | – | – | NA | R | + | 1 | 22 | NA | LR | N | 15 | Alive |
Shirabe et al [22] | 58/F | Asian | + | – | NA | + | + | R | + | 1 | 22 | NA | LR | N | 78 | Alive |
Patel et al [23] | 74/F | White | – | – | – | – | – | NA | – | Multi | 65 | + | LR | Y | 24 | Died |
 | 65/M | White | – | – | – | – | – | NA | + | 1 | 48 | – | LR | N | 60 | Died |
 | 65/F | White | – | – | – | – | + | NA | + | 1 | 13 | – | LR | N | 108 | Alive |
 | 70/F | White | – | – | – | – | + | NA | + | 1 | 27 | – | LR | N | 72 | Alive |
 | 61/F | White | – | – | – | – | – | NA | – | Multi | 95 | + | LR | N | 4 | Died |
 | 78/M | White | – | – | – | – | – | NA | + | 1 | 105 | + | LR | Y | 48 | Alive |
 | 78/F | White | – | – | – | – | – | NA | + | 1 | 60 | – | LR | N | 24 | Alive |
 | 57/F | White | – | – | – | – | – | NA | – | 1 | 130 | + | LR | N | 1 | Died |
Chan et al [24] | 58a/13 M, 7F | NA | 17/20 | 0 | 0 | 8+/20 | 13/20 | NA | 20+/20 | 1 | 38 | NA | LR | NA | 5-y survival: 88% | |
Wada et al [11] | 62a/10 M, 1F | NA | 0/11 | 11/11 | / | 6/11 | NA | NA | NA | NA | 22 | 1+/11 | LR | NA | 5-y survival: 100% |